{
  "id": 15796459,
  "title": "Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration",
  "url": "https://urgent.news/2026/10/20/roche-hansoh-launch-up-to-15b-cancer-adc-collaboration",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-20T19:38:20.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/cancer/roche-hansoh-launch-up-to-15b-cancer-adc-collaboration/"
  },
  "original_language": "en",
  "account": "Roche and Hansoh Pharmaceutical Group have announced a strategic collaboration that could generate over $15 billion for the Chinese drug developer. The partnership will focus on developing multiple antibody-drug conjugate (ADC) programs to treat various cancer types. Roche, the Swiss pharmaceutical giant, will contribute its identified cancer targets, while Hansoh will utilize its ADC technology platform. Boris L. Zaïtra, Head of Corporate Business Development at Roche, commented on the collaboration, stating that it marks an important step in advancing their ADC vision and provides an opportunity to address critical unmet needs in oncology. The partnership was previously announced in October, following Roche's exclusive global license to develop HS-20110, an ADC for colorectal cancer and other solid tumors. Roche agreed to pay Hansoh $80 million upfront and up to $1.45 billion in potential milestone payments for the development of HS-20110. Hansoh's executive director, Eliza Sun, expressed delight in strengthening the collaboration with Roche, highlighting their shared commitment to advancing ADC innovation and accelerating the development of transformative cancer therapies.",
  "summary": "The companies' strategic collaboration will consist of two preclinical Hansoh ADC programs and “multiple” ADC programs based on Roche-identified targets, to be developed through Hansoh’s ADC technology platform. The post Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}